Range Low Price High Price Comment
30 days $64.64 $73.22 Tuesday, 30th Apr 2024 GILD stock ended at $65.20. This is 1.12% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 1.26% from a day low at $64.82 to a day high of $65.64.
90 days $64.64 $79.03
52 weeks $64.64 $87.86

Historical Gilead Sciences prices

Date Open High Low Close Volume
Mar 09, 2016 $88.94 $89.25 $87.43 $87.41 10 428 100
Mar 08, 2016 $89.65 $90.40 $88.35 $88.23 11 056 800
Mar 07, 2016 $87.11 $90.04 $86.88 $89.22 13 100 600
Mar 04, 2016 $88.30 $89.10 $86.85 $86.79 21 201 900
Mar 03, 2016 $89.13 $89.31 $87.48 $87.41 12 374 600
Mar 02, 2016 $89.60 $89.68 $87.96 $88.37 10 557 200
Mar 01, 2016 $87.90 $89.72 $87.30 $89.26 11 746 100
Feb 29, 2016 $87.87 $89.14 $87.25 $86.83 12 732 500
Feb 26, 2016 $90.61 $90.92 $87.89 $87.68 13 349 700
Feb 25, 2016 $90.00 $90.49 $89.55 $89.73 9 171 500
Feb 24, 2016 $87.41 $89.54 $86.79 $88.93 8 338 400
Feb 23, 2016 $89.10 $89.40 $87.90 $87.93 8 394 500
Feb 22, 2016 $88.35 $89.50 $88.05 $88.67 9 749 400
Feb 19, 2016 $88.20 $88.98 $87.12 $87.02 12 897 800
Feb 18, 2016 $89.60 $90.95 $88.93 $88.56 11 427 500
Feb 17, 2016 $91.09 $91.50 $88.66 $88.93 22 772 800
Feb 16, 2016 $90.72 $91.28 $89.89 $90.71 12 278 000
Feb 12, 2016 $88.66 $89.88 $86.68 $89.01 11 311 700
Feb 11, 2016 $86.50 $88.45 $86.01 $86.94 13 013 400
Feb 10, 2016 $88.69 $89.85 $87.54 $87.38 13 462 300
Feb 09, 2016 $84.20 $88.48 $84.10 $86.83 14 322 700
Feb 08, 2016 $84.19 $86.65 $83.86 $84.85 19 111 300
Feb 05, 2016 $86.68 $88.02 $84.45 $84.73 15 732 800
Feb 04, 2016 $86.02 $87.45 $85.61 $86.26 14 538 700
Feb 03, 2016 $84.91 $86.99 $83.87 $85.98 24 497 700
Click to get the best stock tips daily for free!

About Gilead Sciences

Gilead Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT